Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· LongevityAudio: English

Dietary Fiber After 55: The WHO Meta-Analysis That Redraws the Nutrition Evidence

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

A World Health Organization commissioned meta-analysis of one hundred eighty-five prospective studies found that high dietary fiber intake was associated with a fifteen to thirty percent lower risk of all-cause mortality, coronary heart disease, type 2 diabetes, and colorectal cancer — and identified an optimal intake range most adults do not come close to reaching. In 2019, The Lancet published a comprehensive meta-analysis commissioned by the World Health Organization to establish the evidence base for updated global dietary guidelines. The team synthesized one hundred eighty-five prospective studies and fifty-eight clinical trials. Their core finding: compared to people with low dietary fiber intake, those with high intake had a fifteen to thirty percent lower risk of dying from any cause, from coronary heart disease, from stroke, and of developing colorectal cancer and type 2 diabetes. And the intake level associated with maximum benefit — twenty-five --- Paper cited: Carbohydrate quality and human health: a series of systematic reviews and meta-analyses Authors: Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L Journal: The Lancet Year: 2019 DOI: 10.1016/S0140-6736(18)31809-9 --- Subscribe for one peer-reviewed paper made practical, every Tuesday and Friday. Free guide: How to Read Your Biomarker Panel at 55+ - {{LEAD_MAGNET_URL}} --- EDUCATIONAL CONTENT - NOT MEDICAL ADVICE This video is for general educational and informational purposes only. It summarizes peer-reviewed research. It does NOT constitute: - Medical advice, diagnosis, or treatment - Recommendations to start, stop, or change any medication - Dosing instructions for supplements or interventions - A substitute for consultation with a licensed physician Before applying anything discussed: - Talk to your physician, especially if you take prescription medications (statins, metformin, blood thinners, antihypertensives, GLP-1 agonists, etc.) - Discuss interactions, contraindications, and your individual risk profile - Get baseline biomarkers before changing your regimen if relevant Specific cautions: - Intermittent fasting: not appropriate for people with diabetes (especially Type 1), history of eating disorders, pregnancy, or underweight status without medical supervision. - Strength/Zone-2 training: medical clearance recommended for cardiovascular or joint conditions before initiating new training loads. - Supplements: third-party tested products preferred; verify drug interactions. AFFILIATE DISCLOSURE (FTC compliant): Some links in the description may be affiliate links. We may earn a commission at no additional cost to you. We only feature products and tools relevant to the research discussed. AI-ASSISTED PRODUCTION: Voice narration is generated via Edge TTS (Microsoft Neural Voice). Research, scriptwriting, and review are conducted by a human editor before publication. Reviewed: 2026-08-29

Longevity · 11 min · Source published: 2026-08-29

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…